Point72 (Difc) LTD Century Therapeutics, Inc. Transaction History

Point72 (Difc) LTD

$2.64 Trillion
Q2 2025

A detailed history of Point72 (Difc) LTD transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 1,749 shares of IPSC stock, worth $891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,749

Holding current value

$891

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$0.39 - $0.63 $682 - $1,101	1,749 New	1,749 $977,000
Q1 2024 May 15, 2024	BUY	$3.19 - $5.32 $20,527 - $34,234	6,435 New	6,435 $26.9 Million

Others Institutions Holding IPSC

# of Institutions

Shares Held

23.8M

Call Options Held

33.4K

Put Options Held

Bain Capital Life Sciences Investors, LLC Boston, MA

5.41M
Shares

$2.76 Million
0.91% of portfolio
Black Rock Inc. New York, NY

2.9M
Shares

$1.48 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.11M
Shares

$1.08 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.02M
Shares

$1.03 Million
0.0% of portfolio
Dafna Capital Management LLC Los Angeles, CA

1.7M
Shares

$869,158
0.28% of portfolio

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $30M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Account